Florida Cancer Institute-New Hope

New Port Richey, Florida 34655

0 studies enrolling now · 10 studies all time

What they study most

Adenocarcinoma of the Lung, Androgen-independent Prostate Cancer, Breast Cancer, Metastatic Non-Small Cell Lung Cancer, Non-Hodgkin's Lymphoma (NHL), Non-small Cell Lung Cancer, Non-small-cell Lung Cancer, Pancreatic Adenocarcinoma, Prostate Cancer, Urothelial Cancer

Studies at this site

• Study of the Safety and Efficacy of TH-302 in Combination With Gemcitabine Compared With Gemcitabine Alone in Previously Untreated Patients With Pancreatic Adenocarcinoma — Completed
• A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer — Completed
• A Safety and Efficacy Study of Farletuzumab in Participants With Adenocarcinoma of the Lung — Completed
• Study to Evaluate Safety and Effectiveness of Lenalidomide in Combination With Docetaxel and Prednisone for Patients With Castrate-Resistant Prostate Cancer — Completed
• Mitoxantrone ± Cetuximab 2nd Line Androgen Independent Prostate Cancer (AIPC) — Completed
• Gemzar, Cisp, Sunitinib Urothelial Ca — Completed
• A Study of Erlotinib (Tarceva) After Surgery With or Without Adjuvant Chemotherapy in Non-Small Cell Lung Carcinoma (NSCLC) Patients Who Have Epidermal Growth Factor Receptor (EGFR) Positive Tumors — Completed
• Study to Evaluate the Efficacy and Safety of Treatment With Bendamustine in Combination With Ofatumumab in Previously Untreated Patients With Indolent B-Cell Non-Hodgkin's Lymphoma (NHL) — Completed
• A Study of Nimotuzumab in Combination With Radiation Therapy in Patients With Brain Metastases — Stopped early
• A Study of Nimotuzumab in Combination With External Radiotherapy in Non-Small Cell Lung Cancer — Stopped early